Christopher Ellis - Jun 28, 2022 Form 4 Insider Report for Vaccitech plc (VACC)

Role
Chief Operating Officer
Signature
/s/ William Enright, Attorney-in-Fact
Stock symbol
VACC
Transactions as of
Jun 28, 2022
Transactions value $
-$30
Form type
4
Date filed
7/15/2022, 04:06 PM
Previous filing
Feb 11, 2022
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VACC Ordinary Shares Options Exercise $0.00 +5 +6.67% $0.00* 80 Jun 28, 2022 Direct F1
transaction VACC Ordinary Shares Sale -$30 -5 -6.25% $6.00 75 Jun 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Options Exercise $0 -5 -0.01% $0.00 51K Jun 28, 2022 Ordinary Shares 5 $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.